بدائل البحث:
small decrease » small increased (توسيع البحث)
يعرض 641 - 660 نتائج من 2,545 نتيجة بحث عن '((((somatic decrease) OR (small decrease))) OR (dramatic decrease))', وقت الاستعلام: 0.34s تنقيح النتائج
  1. 641

    Data Sheet 1_Vitexicarpin suppresses colorectal and non-small cell lung cancer via selective inhibition of Anoctamin 1.docx حسب Yohan Seo (773204)

    منشور في 2025
    "…<p>Colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) remain among the most challenging malignancies to treat due to therapy complexity, adverse events, and dose-limiting toxicities, which often result in treatment failure. …"
  2. 642
  3. 643

    Supplementary file 1_Temporal interaction information and laser evoked responses: preliminary results in fibromyalgia patients with small fibers pathology.docx حسب Livio Clemente (22152382)

    منشور في 2025
    "…</p>Results<p>Control subjects generally exhibited synergy clusters corresponding to N2 and P2 peaks, whereas patients with fibromyalgia (FM), particularly those with distal denervation, exhibited increased redundancy and decreased synergy.</p>Conclusion<p>Patients with FM and small fiber pathology exhibited an alteration in higher-order integration mechanisms due to a complex interaction between cortical processing of pain and denervation of nociceptive fibers.…"
  4. 644

    <b>FOXP3 influences recruitment and polarization of macrophages via regulating CCL5 in non-small cell lung cancer</b> حسب Zhihua Ye (20486717)

    منشور في 2024
    "…<p dir="ltr">Forkhead box P3<b> (</b>FOXP3) plays a key role in the malignant progression of non-small cell lung cancer (NSCLC). However, the regulatory effect of FOXP3 on the biological activity of macrophages in NSCLC has not yet been reported.…"
  5. 645

    Data Sheet 1_Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study.docx حسب Luigi Liguori (9434405)

    منشور في 2024
    "…Introduction<p>Immune checkpoint inhibitor (ICI)-based immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-L1) has radically changed the management of many types of solid tumors including non-small cell lung cancer (NSCLC). Many clinical trials have demonstrated that ICIs improve the survival and the quality of life of patients with advanced non oncogene NSCLC as compared to standard therapies. …"
  6. 646
  7. 647
  8. 648
  9. 649

    Prevalences of skin injury on the back. حسب Lisa Jung (13264758)

    منشور في 2024
    الموضوعات:
  10. 650
  11. 651
  12. 652

    Prevalences of keel bone damage. حسب Lisa Jung (13264758)

    منشور في 2024
    الموضوعات:
  13. 653
  14. 654
  15. 655
  16. 656
  17. 657
  18. 658
  19. 659
  20. 660